Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response and Toxicity to the Second Course of 3 Cycles of 177Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Eidherr H, Mitterhauser M, Vraka C, Langsteger W, Hacker M, Haug AR. Rasul S, et al. Among authors: shariat sf. Cancers (Basel). 2021 May 20;13(10):2489. doi: 10.3390/cancers13102489. Cancers (Basel). 2021. PMID: 34065303 Free PMC article.
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Szarvas T, Tschirdewahn S, Niedworok C, Kramer G, Sevcenco S, Reis H, Shariat SF, Rübben H, vom Dorp F. Szarvas T, et al. Among authors: shariat sf. Int J Cancer. 2014 Oct 1;135(7):1596-604. doi: 10.1002/ijc.28808. Epub 2014 Mar 4. Int J Cancer. 2014. PMID: 24615121 Free article.
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Tschirdewahn S, et al. Among authors: shariat sf. Urol Oncol. 2014 Jul;32(5):663-9. doi: 10.1016/j.urolonc.2014.02.004. Epub 2014 May 9. Urol Oncol. 2014. PMID: 24814404
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H, Mathieu R, Lucca I, Hiess M, Hübner N, Al Hussein Al Awamlh B, Lee R, Briganti A, Karakiewicz P, Lotan Y, Roupret M, Rink M, Kluth L, Loidl W, Seitz C, Klatte T, Kramer G, Susani M, Shariat SF. Fajkovic H, et al. Among authors: shariat sf. Urol Oncol. 2016 May;34(5):233.e1-6. doi: 10.1016/j.urolonc.2015.10.013. Epub 2016 Mar 10. Urol Oncol. 2016. PMID: 26973136
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL, Bahadori A, Mathieu R, Haitel A, Grubmüller B, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Cunha IW, Zequi SC, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Jacquet-Kammerer S, Bensalah K, Lotan Y, Bachmann A, Rink M, Briganti A, Shariat SF. Favaretto RL, et al. Among authors: shariat sf. World J Urol. 2017 Jan;35(1):113-120. doi: 10.1007/s00345-016-1835-1. Epub 2016 Apr 29. World J Urol. 2017. PMID: 27129576 Free PMC article.
64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies.
Grubmüller B, Baum RP, Capasso E, Singh A, Ahmadi Y, Knoll P, Floth A, Righi S, Zandieh S, Meleddu C, Shariat SF, Klingler HC, Mirzaei S. Grubmüller B, et al. Among authors: shariat sf. Cancer Biother Radiopharm. 2016 Oct;31(8):277-286. doi: 10.1089/cbr.2015.1964. Epub 2016 Oct 7. Cancer Biother Radiopharm. 2016. PMID: 27715146
1,824 results